Avatrombopag

CAS No. 570406-98-3

Avatrombopag ( AKR-501; E5501; YM477 )

Catalog No. M20798 CAS No. 570406-98-3

Avatrombopag is a new oral thrombopoietin (TPO) receptor agonist activating TPO receptor and increasing megakaryocytic proliferation/differentiation and platelet production.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 76 In Stock
5MG 111 In Stock
10MG 177 In Stock
25MG 321 In Stock
50MG 537 In Stock
100MG 767 In Stock
500MG 1557 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Avatrombopag
  • Note
    Research use only not for human use.
  • Brief Description
    Avatrombopag is a new oral thrombopoietin (TPO) receptor agonist activating TPO receptor and increasing megakaryocytic proliferation/differentiation and platelet production.
  • Description
    Avatrombopag is a new oral thrombopoietin (TPO) receptor agonist activating TPO receptor and increasing megakaryocytic proliferation/differentiation and platelet production.
  • Synonyms
    AKR-501; E5501; YM477
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    TPO
  • Research Area
    Cardiovascular Disease
  • Indication
    Idiopathic thrombocytopenic purpura

Chemical Information

  • CAS Number
    570406-98-3
  • Formula Weight
    649.65
  • Molecular Formula
    C29H34Cl2N6O3S2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:32 mg/mL (49.26 mM)
  • SMILES
    O=C(Nc1nc(-c2cc(Cl)cs2)c(N2CCN(C3CCCCC3)CC2)s1)c1cnc(N2CCC(C(=O)O)CC2)c(Cl)c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Xu H Cai R.Avatrombopag for the treatment of thrombocytopenia in patients with chronic liver disease.Expert Rev Clin Pharmacol. 2019 Sep;12(9):859-865?
molnova catalog
related products
  • VH032-cyclopropane-F

    VH032-cyclopropane-F is a VH032-based VHL ligand. VH032-cyclopropane-F can be connected to the ligand for protein by a linker to form PROTACs. PROTAC 1 is a partial degrader of SMARCA2 and SMARCA4.

  • Vasicinone

    Vasicinone may act as a hepatoprotective agent. (±)-Vasicinone has significant antitussive, expectorant, and bronchodilating activities.

  • Orthosiphol A

    Orthosiphol A is a natural product for research related to life sciences.